Dual-Listed Lithium Miner Announces Provisional Patent News

Dual-Listed Lithium Miner Announces Provisional Patent News

By: Tomas Ronolski - AllPennyStocks.com News

Thursday, September 7, 2023

The need for lithium remains strong as the world moves away from fossil fuels. This company’s patent-pending system is based on the extraction of lithium from solids using both products of a chlor-alkali process, hydrochloric acid and sodium hydroxide and has just obtained a provisional patent with the U.S. Patent and Trademark Office, U.S. Department of Commerce. Century Lithium Corp.’s (TSXV: LCE) (OTCQX: CYDVF) provisional patent is titled System and Method for Extracting Lithium from Clay and Other Materials in a Chloride Solution Using Individualized Pretreatments

The patent-pending process encompasses the company's flowsheet, as developed at its Lithium Extraction Facility in Amargosa Valley, Nevada and protects Century Lithium's intellectual property pertaining to the handling of solutions derived from the treatment of solid materials, including clays from their Clayton Valley Lithium Project in Nevada.

Century Lithium is an advanced-stage lithium company focused on developing its 100%-owned Clayton Valley Lithium Project in west-central Nevada. The firm is in the pilot stage of testing on material from its lithium-bearing claystone deposit at its Nevada facility and progressing towards completing a Feasibility Study and permitting, with the goal of becoming a domestic producer of lithium for the growing electric vehicle and battery storage market. Canadian shares were trading at $0.72 in morning trade.

 


Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Dually-Listed Healthcare Stock Finds Mid-Week Success
Small Cap Massively Bid Following Key Q1 Earnings Beat
Traders Rush To Buy Biotech Following Q1 Earnings Beat
Most Popular
FREE Newsletter


Back to Top